MBCOF

MARVEL BIOSCIENCES CORP by MARVEL BIOSCIENCES CORP. (MBCOF)

About MARVEL BIOSCIENCES CORP by MARVEL BIOSCIENCES CORP. (MBCOF)

Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. It develops several patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases, and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The company was founded on June 14, 2021 and is headquartered in Calgary, Canada.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.12
52 Week Low
$0.04
Market cap
3.1M
Dividend yield
0.00%
Volume
--
Avg. volume
28,840
P/E ratio
-2.49

MARVEL BIOSCIENCES CORP by MARVEL BIOSCIENCES CORP. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.12
52 Week Low
$0.04
Market cap
3.1M
Dividend yield
0.00%
Volume
--
Avg. volume
28,840
P/E ratio
-2.49